161 related articles for article (PubMed ID: 23176182)
1. Comparative cardiovascular safety of dementia medications: a cross-national study.
Fosbøl EL; Peterson ED; Holm E; Gislason GH; Zhang Y; Curtis LH; Køber L; Iwata I; Torp-Pedersen C; Setoguchi S
J Am Geriatr Soc; 2012 Dec; 60(12):2283-9. PubMed ID: 23176182
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Hernandez RK; Farwell W; Cantor MD; Lawler EV
J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
[TBL] [Abstract][Full Text] [Related]
3. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
[TBL] [Abstract][Full Text] [Related]
4. How do we treat people with dementia in Croatia.
Mimica N; Presecki P
Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
[TBL] [Abstract][Full Text] [Related]
5. Dementia medications in palliative care #174.
Morrison LJ; Liao S
J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
[No Abstract] [Full Text] [Related]
6. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
7. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.
Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Lavikainen P; Hartikainen S; Taipale H
Ann Med; 2017 May; 49(3):230-239. PubMed ID: 27786552
[TBL] [Abstract][Full Text] [Related]
8. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors.
Shega JW; Ellner L; Lau DT; Maxwell TL
J Palliat Med; 2009 Sep; 12(9):779-83. PubMed ID: 19622011
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic use and myocardial infarction in older patients with treated dementia.
Pariente A; Fourrier-Réglat A; Ducruet T; Farrington P; Béland SG; Dartigues JF; Moore N; Moride Y
Arch Intern Med; 2012 Apr; 172(8):648-53; discussion 654-5. PubMed ID: 22450214
[TBL] [Abstract][Full Text] [Related]
15. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.
Kim DH; Brown RT; Ding EL; Kiel DP; Berry SD
J Am Geriatr Soc; 2011 Jun; 59(6):1019-31. PubMed ID: 21649634
[TBL] [Abstract][Full Text] [Related]
16. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Hartmann S; Möbius HJ
Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
[TBL] [Abstract][Full Text] [Related]
18. Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008.
Lazzeroni LC; Halbauer JD; Ashford JW; Noda A; Hernandez B; Azor V; Hozack N; Hasson N; Henderson VW; Yesavage JA; Tinklenberg JR
J Alzheimers Dis; 2013; 36(4):791-8. PubMed ID: 23703151
[TBL] [Abstract][Full Text] [Related]
19. The impact of Medicare prescription drug coverage on the use of antidementia drugs.
Fowler NR; Chen YF; Thurton CA; Men A; Rodriguez EG; Donohue JM
BMC Geriatr; 2013 Apr; 13():37. PubMed ID: 23621892
[TBL] [Abstract][Full Text] [Related]
20. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
